Cargando…

Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome

The purpose of this study was to implore the association among clinical features, long-term fertility outcomes and the anatomical location of adenomyosis identified by ultrasound. We collected data of non-pregnant patients between 20 and 40 years old who had undergone surgical exploration for benign...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jinghua, Wu, Yushi, Li, Xiaoyan, Gu, Zhiyue, Zhang, Chenyu, Yan, Hailan, Dai, Yi, Leng, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485030/
https://www.ncbi.nlm.nih.gov/pubmed/37679426
http://dx.doi.org/10.1038/s41598-023-40816-z
_version_ 1785102705412276224
author Shi, Jinghua
Wu, Yushi
Li, Xiaoyan
Gu, Zhiyue
Zhang, Chenyu
Yan, Hailan
Dai, Yi
Leng, Jinhua
author_facet Shi, Jinghua
Wu, Yushi
Li, Xiaoyan
Gu, Zhiyue
Zhang, Chenyu
Yan, Hailan
Dai, Yi
Leng, Jinhua
author_sort Shi, Jinghua
collection PubMed
description The purpose of this study was to implore the association among clinical features, long-term fertility outcomes and the anatomical location of adenomyosis identified by ultrasound. We collected data of non-pregnant patients between 20 and 40 years old who had undergone surgical exploration for benign gynecological conditions at our institution between January 2010 and December 2017. A total of 158 women met the inclusion criteria and were allocated into three groups according to the ultrasound-determined adenomyosis anatomical location: anterior (Group A), posterior (Group B), both posterior and anterior (Group C). 44.3% (70/158) adenomyosis was located at the posterior side. History of miscarriage and parity were significantly higher in Group C (p = 0.036 and 0.001 respectively). Group C also had a higher concurrence rate of ovarian endometrioma (OEM) (80.4%, p = 0.002), pelvic adhesion (80.4%, P = 0.003) and the revised American Fertility Society (rAFS) Score (median64, range2-100, P < 0.001), while a significantly lower rate of concurrent peritoneal endometriosis (P = 0.01). Group B showed a relative higher rate of coexistent heavy menstrual bleeding (28.6%, p = 0.04) and oviduct obstruction (24.3%, P = 0.038). Group A had a higher proportion of coexistent leiomyoma (53.1%, P = 0.002). There were no significant differences between group A, B, and C in terms of pain symptoms, endometrial polyps, operation time, and endometriosis fertility index score and other basic characters (p > 0.05). During the follow-up, 59.2% (61/103) patients had clinical pregnancies, and 26.2% (16/61) of them experienced pregnancy loss. Total in vitro fertilization and embryo transfer pregnancy rate was 64.6% (42/65) and spontaneous pregnancy rate was 50.0% (19/38). The Kaplan–Meier curves demonstrated significant lower cumulative pregnancy rate in Group C than Group A and Group B (p = 0.01). Severe obstetric complications such as placenta previa, placenta accreta, preeclampsia, and preterm birth were only found in women with adenomyosis located in the posterior side. In conclusion, types of adenomyosis based on sonographic location had different clinical features and pregnancy outcome. Patients with adenomyosis lesion in both anterior and posterior sides had higher combination of OEM, pelvic adhesion and rAFS score.
format Online
Article
Text
id pubmed-10485030
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104850302023-09-09 Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome Shi, Jinghua Wu, Yushi Li, Xiaoyan Gu, Zhiyue Zhang, Chenyu Yan, Hailan Dai, Yi Leng, Jinhua Sci Rep Article The purpose of this study was to implore the association among clinical features, long-term fertility outcomes and the anatomical location of adenomyosis identified by ultrasound. We collected data of non-pregnant patients between 20 and 40 years old who had undergone surgical exploration for benign gynecological conditions at our institution between January 2010 and December 2017. A total of 158 women met the inclusion criteria and were allocated into three groups according to the ultrasound-determined adenomyosis anatomical location: anterior (Group A), posterior (Group B), both posterior and anterior (Group C). 44.3% (70/158) adenomyosis was located at the posterior side. History of miscarriage and parity were significantly higher in Group C (p = 0.036 and 0.001 respectively). Group C also had a higher concurrence rate of ovarian endometrioma (OEM) (80.4%, p = 0.002), pelvic adhesion (80.4%, P = 0.003) and the revised American Fertility Society (rAFS) Score (median64, range2-100, P < 0.001), while a significantly lower rate of concurrent peritoneal endometriosis (P = 0.01). Group B showed a relative higher rate of coexistent heavy menstrual bleeding (28.6%, p = 0.04) and oviduct obstruction (24.3%, P = 0.038). Group A had a higher proportion of coexistent leiomyoma (53.1%, P = 0.002). There were no significant differences between group A, B, and C in terms of pain symptoms, endometrial polyps, operation time, and endometriosis fertility index score and other basic characters (p > 0.05). During the follow-up, 59.2% (61/103) patients had clinical pregnancies, and 26.2% (16/61) of them experienced pregnancy loss. Total in vitro fertilization and embryo transfer pregnancy rate was 64.6% (42/65) and spontaneous pregnancy rate was 50.0% (19/38). The Kaplan–Meier curves demonstrated significant lower cumulative pregnancy rate in Group C than Group A and Group B (p = 0.01). Severe obstetric complications such as placenta previa, placenta accreta, preeclampsia, and preterm birth were only found in women with adenomyosis located in the posterior side. In conclusion, types of adenomyosis based on sonographic location had different clinical features and pregnancy outcome. Patients with adenomyosis lesion in both anterior and posterior sides had higher combination of OEM, pelvic adhesion and rAFS score. Nature Publishing Group UK 2023-09-07 /pmc/articles/PMC10485030/ /pubmed/37679426 http://dx.doi.org/10.1038/s41598-023-40816-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Shi, Jinghua
Wu, Yushi
Li, Xiaoyan
Gu, Zhiyue
Zhang, Chenyu
Yan, Hailan
Dai, Yi
Leng, Jinhua
Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome
title Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome
title_full Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome
title_fullStr Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome
title_full_unstemmed Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome
title_short Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome
title_sort effects of localization of uterine adenomyosis on clinical features and pregnancy outcome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485030/
https://www.ncbi.nlm.nih.gov/pubmed/37679426
http://dx.doi.org/10.1038/s41598-023-40816-z
work_keys_str_mv AT shijinghua effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome
AT wuyushi effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome
AT lixiaoyan effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome
AT guzhiyue effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome
AT zhangchenyu effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome
AT yanhailan effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome
AT daiyi effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome
AT lengjinhua effectsoflocalizationofuterineadenomyosisonclinicalfeaturesandpregnancyoutcome